168 related articles for article (PubMed ID: 29972690)
1. Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.
Girard MC; Acevedo GR; López L; Ossowski MS; Piñeyro MD; Grosso JP; Fernandez M; Hernández Vasquez Y; Robello C; Gómez KA
Immunology; 2018 Nov; 155(3):367-378. PubMed ID: 29972690
[TBL] [Abstract][Full Text] [Related]
2. The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.
López L; Chiribao ML; Girard MC; Gómez KA; Carasi P; Fernandez M; Hernandez Y; Robello C; Freire T; Piñeyro MD
Immunology; 2021 May; 163(1):46-59. PubMed ID: 33410127
[TBL] [Abstract][Full Text] [Related]
3. Tryparedoxin peroxidases from Trypanosoma cruzi: high efficiency in the catalytic elimination of hydrogen peroxide and peroxynitrite.
Piñeyro MD; Arcari T; Robello C; Radi R; Trujillo M
Arch Biochem Biophys; 2011 Mar; 507(2):287-95. PubMed ID: 21167808
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization dynamics and functionality of Trypanosoma cruzi cytosolic tryparedoxin peroxidase as peroxidase and molecular chaperone.
Piñeyro MD; Arias D; Ricciardi A; Robello C; Parodi-Talice A
Biochim Biophys Acta Gen Subj; 2019 Oct; 1863(10):1583-1594. PubMed ID: 31265897
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.
Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE
Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095
[TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease?
Piñeyro MD; Parodi-Talice A; Arcari T; Robello C
Gene; 2008 Jan; 408(1-2):45-50. PubMed ID: 18022330
[TBL] [Abstract][Full Text] [Related]
7. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
Bontempi I; Fleitas P; Poato A; Vicco M; Rodeles L; Prochetto E; Cabrera G; Beluzzo B; Arias D; Racca A; Guerrero S; Marcipar I
Immunotherapy; 2017 Jun; 9(7):555-565. PubMed ID: 28595515
[TBL] [Abstract][Full Text] [Related]
8. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
[TBL] [Abstract][Full Text] [Related]
9. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis.
Suman SS; Amit A; Singh KP; Gupta P; Equbal A; Kumari A; Topno RK; Ravidas V; Pandey K; Bimal S; Das P; Ali V
Cytokine; 2018 Aug; 108():1-8. PubMed ID: 29554571
[TBL] [Abstract][Full Text] [Related]
11. Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target.
González-Chávez Z; Olin-Sandoval V; Rodíguez-Zavala JS; Moreno-Sánchez R; Saavedra E
Biochim Biophys Acta; 2015 Feb; 1850(2):263-73. PubMed ID: 25450181
[TBL] [Abstract][Full Text] [Related]
12. Antibody Repertoires Identify β-Tubulin as a Host Protective Parasite Antigen in Mice Infected With
Montalvão F; Nascimento DO; Nunes MP; Koeller CM; Morrot A; Lery LMS; Bisch PM; Teixeira SMR; Vasconcellos R; Freire-de-Lima L; Lopes MF; Heise N; DosReis GA; Freire-de-Lima CG
Front Immunol; 2018; 9():671. PubMed ID: 29706955
[TBL] [Abstract][Full Text] [Related]
13. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
[TBL] [Abstract][Full Text] [Related]
14. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: immune response and functional heart damage induced in mice by the main linear B-cell epitope of parasite ribosomal P proteins.
Motrán CC; Cerbán FM; Rivarola W; Iosa D; Vottero de Cima E
Exp Parasitol; 1998 Mar; 88(3):223-30. PubMed ID: 9562426
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites.
Pérez Brandán C; Mesias AC; Acuña L; Teixeira TL; da Silva CV
Mem Inst Oswaldo Cruz; 2019; 114():e180571. PubMed ID: 31116244
[TBL] [Abstract][Full Text] [Related]
17. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi in the opossum Didelphis marsupialis: parasitological and serological follow-up of the acute infection.
Jansen AM; Leon L; Machado GM; da Silva MH; Souza-Leão SM; Deane MP
Exp Parasitol; 1991 Oct; 73(3):249-59. PubMed ID: 1915740
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
20. Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas' disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins.
Longhi SA; Atienza A; Perez Prados G; Buying A; Balouz V; Buscaglia CA; Santos R; Tasso LM; Bonato R; Chiale P; Pinilla C; Judkowski VA; Gómez KA
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2906. PubMed ID: 24901991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
